Track Your Manuscript:
Enter Correct Manuscript Reference Number:

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Order Your Article Before Print Subscribe to this Journal

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a quick track basis, to ensure timely review and publication of much needed research

Book Proposal

Become an Executive Guest Editor

New Journal Proposal

Become a Section Editor

Become a Reviewer

Join Editorial Board

Thematic Issue Proposal

Online Abstract Submission

Thematic Issue Proposal

Guest Editors who wish to submit an issue proposal to Endocrine, Metabolic & Immune Disorders - Drug Targets are requested to complete the following online form. The proposal of thematic issue will then be immediately forwarded to the Editor-in-Chief/Co-Editors/Executive Editor(s) of Endocrine, Metabolic & Immune Disorders - Drug Targets who will then inform Guest Editors with a decision about the submitted proposal.

Note: * Required fields

	*Title of the proposed Thematic Issue:

	*Guest Editor Name:

	*Guest Editor Affiliation:

	*Guest Editor's List of Publications (Last - 5 Years):

	*Issue Description:

	Proposal Keywords:

	*Thematic Issue Type:

	*Total Articles:

	Tentative date for submission of ALL manuscripts:

Contact Information:

	*Title:
	*First Name:
	*Last Name:
	User Category:
	*Address:
	*City/Town:
	*Country:
	State/Province:
	ZIP/Postal code:
	*E-mail:
	Phone:
	Fax:

Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.

Scopus CiteScore Metrics: 1.79

Society Accreditations